Metraipolis › archive › dc_3f2d52d2459f

Cost-effectiveness of emicizumab for the treatment of hemophilia A: a systematic review — Europe PMC PMID:41127589

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41127589
DOI
10.3389/fpubh.2025.1658760
License (as archived)
solo-consultazione
Archived
2026-11-09T13:16:55.129Z
SHA-256 of the archived text
2b2d80a8abe0fccaf9ce3973ad44bdb439175ea61f56028efac406f3fbc29527
Stable URL of this page
https://metraipolis.com/documento/dc_3f2d52d2459f

How to cite

Cost-effectiveness of emicizumab for the treatment of hemophilia A: a systematic review — Europe PMC PMID:41127589 — Europe PMC (en), https://europepmc.org/article/MED/41127589 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3f2d52d2459f (Metraipolis archive dc_3f2d52d2459f, sha256 2b2d80a8abe0fccaf9ce3973ad44bdb439175ea61f56028efac406f3fbc29527)
BibTeX
@misc{dc3f2d52d2459f,
  title = {Cost-effectiveness of emicizumab for the treatment of hemophilia A: a systematic review — Europe PMC PMID:41127589},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41127589},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3f2d52d2459f; sha256 2b2d80a8abe0fccaf9ce3973ad44bdb439175ea61f56028efac406f3fbc29527},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41127589. Agents can read the archived copy with the MCP tool read_document.